Limited tenders are invited for purchase of human isophane insulin
40 iu/ml 10ml vial (intermediate acting)
Berghold et al., "Long-acting insulin analogues versus NPH insulin (human isophane insulin
) for type 2 diabetes mellitus," Cochrane Database of Systematic Reviews, no.
Four patients administered three injections per day: Actraphane before breakfast, soluble insulin (Actrapid) before supper, and isophane insulin
(Protaphane) at 21h00, and only one was on a basal-bolus regimen (isophane insulin
at 21h00 hours, with soluble insulin boluses before each meal).
Diabetes is covered by soluble insulin, and intermediate-acting insulin (compound insulin zinc suspension or isophane insulin
Patients were randomized to either glargine (Lantus; Aventis) or human premix insulin (mixture of 30% neutral soluble insulin and 70% isophane insulin
) to be administered subcutaneously at bedtime (glargine) or twice a day (human premix insulin), using a pen injector or insulin syringe as preferred by patient for 24 weeks.
01.Inj Premixed BiphasicInsulin (30% Human Neutral Plus 70% human isophane insulin
Various insulin regimens are available: very rapid acting (lispro and aspart), rapid acting (regular), intermediate acting (isophane insulin
[NPH] and lente) and very long acting (ultralente and glargine).
Tenders invited for Insulin human usp 30% as soluble insulin and 70% as isophane insulin
(19) TABLE 2 Insulin formulations Effective Insulin * Onset Peak duration (h) Rapid-acting Lispro 5-15 min 30-90 min 5 Aspart 5-15 min 30-90 min 5 Short-acting Regular U100 30-60 min 2-3 h 5-8 Regular U500 30-60 min 2-3 h 5-8 Intermediate-acting Isophane insulin
2-4 h 4-10 h 10-16 (NPH) Insulin zinc 2-4 h 4-12 h 12-18 Long-acting Insulin zinc 6-10 h 10-16 h 18-24 extended Insulin glargine 2-4 h ([dagger]) No pronounced 20-24 peak Premixed 70% NPH/ 30-60 min Dual 10-16 30% regular 50% NPH/ 30-60 min Dual 10-16 50% regular 75% NPL/ 5-15 min Dual 10-16 25% lispro 70% NP/ 5-15 min Dual 10-16 30% aspart * Assuming 0.1-0.2 U/kg per injection; onset and duration may vary by injection site (except for insulin glargine).
insulin human, biosynthetic (isophane insulin
Contract awarded for 82014218-human biphasic insulin mixture of 30% human neutral insulin and 70% human isophane insulin
Tenders are invited for Procurement of medicine for Inj Insulin Premixed biphasic 40 iu per ml (30% human neutral plus 70% human isophane insulin
), 10 ml Inj.